Recent quarter: Total Revenue: $26,581,826 RETAIL REVENUE: $9,335,707 Net Income: $4,780,417 EPS: .10
Through the first 9 months of fiscal year: Total Revenue: $69,189,574 RETAIL REVENUE: $11,852,602 Net Income: $10,700,169 EPS: .21
This is a company with a run rate now of above $100 million in revenue and as you can see based on the last quarters revenue and profit the retailing stores they acquired should boost margins as they also manufacture drugs and will sell them in their on pharmacies. Because of this their drug manufacturing revenue will probably continue to decline in upcoming quarters because they will be using them in their own stores.
I see this company having net income north of $18 million next year(being conservative as they continue to expand).
What do you guys think about it?
osubucks30
posted
Todays action is why you NEVER buy a lightly traded stock with market orders... Always use limit orders and wait to get filled!! I feel bad for the guy who got the 100 shares at $3.49... what a joke by the MM's on this one!
posted